Table 6.
Dose of corticosterone (μg/mL) |
||||
0 | 25 | 50 | 100 | |
ALT (U/L) | 48.6 (n = 10)a | 4.1 (n = 12)a | 52.1 (n = 11)a,b | 156.0 (n = 12)b |
AST (U/L) | 116.5 (n = 10)a | 41.7 (n = 12)a | 67.9 (n = 11)a,b | 123.5 (n = 12)b |
Albumin (g/dL) | 2.9 (n = 10)a | 15.5 (n = 12)b | 35.0 (n = 11)c | 41.4 (n = 12)c |
Globulin (g/dL) | 2.4 (n = 10)a | 22.0 (n = 10)b | 20.0 (n = 11)b | 19.6 (n = 12)b |
Total bilirubin (mg/dL) | 0.21 (n = 10)a | −0.8 (n = 12)a | 25.5 (n = 11)a,b | 38.9 (n = 12)b |
ALP (U/L) | 92.7 (n = 10)a | −27.3 (n = 12)b | −30.8 (n = 11)b | −32.7 (n = 12)b |
Glucose (mg/dL) | 238.3 (n = 9)a | −15.0 (n = 10)a | −3.1 (n = 11)a | 45.8 (n = 12)b |
Cl (mEq/L) | 107.8 (n = 10)a | −1.0 (n = 12)a | −1.9 (n = 11)a | −6.3 (n = 12)b |
Na (mEq/L) | 151.6 (n = 10)a | 2.1 (n = 12)b | 2.0 (n = 11)b,c | 0.3 (n = 12)a,c |
Ca (mg/dL) | 10.0 (n = 9)a | 1.1 (n = 11)a,b | 7.0 (n = 11)b,c | 8.0 (n = 12)c |
K (mEq/L) | 7.8 (n = 10)a | −3.0 (n = 12)a | −5.5 (n = 11)a | −6.5 (n = 12)a |
Anion gap (mEq/L) | 24.7 (n = 10)a | 24.8 (n = 11)b | 21.6 (n = 11)b | 33.2 (n = 12)b |
Total CO2 (mEq/L) | 26.9 (n = 10)a | −7.1 (n = 11)a | −2.3 (n = 11)a | −5.2 (n = 12)a |
Osmolity (mOsm/kg) | 288.4 (n = 10)a | 11.3 (n = 10)a | 12.2 (n = 11)a | 11.9 (n = 12)a |
Cholesterol (mg/dL) | 86.2 (n = 10)a | 33.0 (n = 12)b | 68.1 (n = 11)c | 70.5 (n = 12)c |
Triglycerides (mg/dL) | 99.3 (n = 3)a | 41.0 (n = 8)a | 97.0 (n = 7)a,b | 167.9 (n = 8)b |
Values for control (0 μg/mL) group expressed as mean values for each analyte; values for treated (25, 50, and 100 μg/mL) groups expressed as % difference ([mean treated value − mean control]/mean control × 100%) from control value. One-way ANOVA with post hoc Tukey multiple comparison tests were used to compared samples with control (0 μg/mL corticosterone, 1% ethanol) values. For each parameter, values with different superscript letters are significantly (P < 0.05) different from each other.